Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis C
Not Applicable
Recruiting
- Conditions
- Patients with chronic hepatitis C virus infection
- Registration Number
- JPRN-UMIN000017703
- Lead Sponsor
- Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe multisystem disease, Severe immnodeficiency 2) P2regnant woman 3) Contraindication to ribavirin 4) Contraindication to sofosbuvir and ribavirin
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virologic response rate The factor associated with sustained virologic response Safety Emergence of drug-resistant virus Cumulative incidence of hepatocellular carcinoma The factor associated with incidence of hepatocellular carcinoma
- Secondary Outcome Measures
Name Time Method